163 related articles for article (PubMed ID: 17765966)
1. Repetitive DNA hypomethylation in the advanced phase of chronic myeloid leukemia.
Roman-Gomez J; Jimenez-Velasco A; Agirre X; Castillejo JA; Navarro G; San Jose-Eneriz E; Garate L; Cordeu L; Cervantes F; Prosper F; Heiniger A; Torres A
Leuk Res; 2008 Mar; 32(3):487-90. PubMed ID: 17765966
[TBL] [Abstract][Full Text] [Related]
2. Differential repetitive DNA methylation in multiple myeloma molecular subgroups.
Bollati V; Fabris S; Pegoraro V; Ronchetti D; Mosca L; Deliliers GL; Motta V; Bertazzi PA; Baccarelli A; Neri A
Carcinogenesis; 2009 Aug; 30(8):1330-5. PubMed ID: 19531770
[TBL] [Abstract][Full Text] [Related]
3. Promoter hypomethylation of the LINE-1 retrotransposable elements activates sense/antisense transcription and marks the progression of chronic myeloid leukemia.
Roman-Gomez J; Jimenez-Velasco A; Agirre X; Cervantes F; Sanchez J; Garate L; Barrios M; Castillejo JA; Navarro G; Colomer D; Prosper F; Heiniger A; Torres A
Oncogene; 2005 Nov; 24(48):7213-23. PubMed ID: 16170379
[TBL] [Abstract][Full Text] [Related]
4. Mutations of the myeloid transcription factor CEBPA are not associated with the blast crisis of chronic myeloid leukaemia.
Pabst T; Stillner E; Neuberg D; Nimer S; Willman CL; List AF; Melo JV; Tenen DG; Mueller BU
Br J Haematol; 2006 May; 133(4):400-2. PubMed ID: 16643447
[TBL] [Abstract][Full Text] [Related]
5. Aberrant methylation of the death-associated protein kinase 1 (DAPK1) CpG island in chronic myeloid leukemia.
Qian J; Wang YL; Lin J; Yao DM; Xu WR; Wu CY
Eur J Haematol; 2009 Feb; 82(2):119-23. PubMed ID: 19018866
[TBL] [Abstract][Full Text] [Related]
6. Haploinsufficiency and acquired loss of Bcl11b and H2AX induces blast crisis of chronic myelogenous leukemia in a transgenic mouse model.
Nagamachi A; Yamasaki N; Miyazaki K; Oda H; Miyazaki M; Honda Z; Kominami R; Inaba T; Honda H
Cancer Sci; 2009 Jul; 100(7):1219-26. PubMed ID: 19432895
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic regulation of PRAME gene in chronic myeloid leukemia.
Roman-Gomez J; Jimenez-Velasco A; Agirre X; Castillejo JA; Navarro G; Jose-Eneriz ES; Garate L; Cordeu L; Cervantes F; Prosper F; Heiniger A; Torres A
Leuk Res; 2007 Nov; 31(11):1521-8. PubMed ID: 17382387
[TBL] [Abstract][Full Text] [Related]
8. Amplification of BCR-ABL and t(3;21) in a patient with blast crisis of chronic myelogenous leukemia.
Phan CL; Megat Baharuddin PJ; Chin LP; Zakaria Z; Yegappan S; Sathar J; Tan SM; Purushothaman V; Chang KM
Cancer Genet Cytogenet; 2008 Jan; 180(1):60-4. PubMed ID: 18068536
[TBL] [Abstract][Full Text] [Related]
9. The role of methylation in CML.
Rachmilewitz EA
Przegl Lek; 2000; 57 Suppl 1():25-6. PubMed ID: 10822991
[TBL] [Abstract][Full Text] [Related]
10. [The methylation of CT gene in chronic myeloid leukemia].
Zhou J; Xue Y; Lin B
Zhonghua Nei Ke Za Zhi; 1997 Jun; 36(6):394-7. PubMed ID: 10374299
[TBL] [Abstract][Full Text] [Related]
11. No evidence for microsatellite instability or consistent loss of heterozygosity at selected loci in chronic myeloid leukaemia blast crisis.
Silly H; Chase A; Mills KI; Apfelbeck U; Sormann S; Goldman JM; Cross NC
Leukemia; 1994 Nov; 8(11):1923-8. PubMed ID: 7967738
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of circadian clock genes in chronic myeloid leukemia: alternative methylation pattern of hPER3.
Yang MY; Chang JG; Lin PM; Tang KP; Chen YH; Lin HY; Liu TC; Hsiao HH; Liu YC; Lin SF
Cancer Sci; 2006 Dec; 97(12):1298-307. PubMed ID: 16999817
[TBL] [Abstract][Full Text] [Related]
13. Additional clonal abnormalities in Philadelphia-positive ALL and CML demonstrate a different cytogenetic pattern at diagnosis and follow different pathways at progression.
Bacher U; Haferlach T; Hiddemann W; Schnittger S; Kern W; Schoch C
Cancer Genet Cytogenet; 2005 Feb; 157(1):53-61. PubMed ID: 15676148
[TBL] [Abstract][Full Text] [Related]
14. Myeloperoxidase cytochemical negativity: an unexpected but intrinsic property of blasts of all phases of chronic myeloid leukemia.
Anand M; Ghara N; Kumar R; Singh S; Sengar M; Panikar N; Raina V; Sharma A
Ann Hematol; 2005 Nov; 84(12):767-70. PubMed ID: 15990995
[TBL] [Abstract][Full Text] [Related]
15. DNA methylation does not regulate JUNB expression in CML: comment on "Downregulation of JUNB mRNA expression in advanced phase chronic myelogenous leukemia" by Hoshino et al. [Leuk. Res. 33 (2009) 1361-1366].
Strathdee G; Ferguson S; Sim A; Brown R
Leuk Res; 2010 May; 34(5):685-6. PubMed ID: 20006998
[No Abstract] [Full Text] [Related]
16. Optimizing outcomes for patients with advanced disease in chronic myelogenous leukemia.
Giles FJ; DeAngelo DJ; Baccarani M; Deininger M; Guilhot F; Hughes T; Mauro M; Radich J; Ottmann O; Cortes J
Semin Oncol; 2008 Feb; 35(1 Suppl 1):S1-17; quiz S18-20. PubMed ID: 18346528
[TBL] [Abstract][Full Text] [Related]
17. GATA-2 L359 V mutation is exclusively associated with CML progression but not other hematological malignancies and GATA-2 P250A is a novel single nucleotide polymorphism.
Zhang SJ; Shi JY; Li JY
Leuk Res; 2009 Aug; 33(8):1141-3. PubMed ID: 19304323
[TBL] [Abstract][Full Text] [Related]
18. Centrosome aberrations in chronic myeloid leukemia correlate with stage of disease and chromosomal instability.
Giehl M; Fabarius A; Frank O; Hochhaus A; Hafner M; Hehlmann R; Seifarth W
Leukemia; 2005 Jul; 19(7):1192-7. PubMed ID: 15858613
[TBL] [Abstract][Full Text] [Related]
19. Is p190 bcr-abl rearrangement necessary for acute transformation in some p210 CML of childhood?
Scrideli CA; de Oliveira FM; Brassesco MS; de Paula Queiroz R; Bernardes JE; Valera ET; Tone LG
Leuk Res; 2009 Mar; 33(3):495-9. PubMed ID: 18495245
[TBL] [Abstract][Full Text] [Related]
20. Malondialdehyde and protein carbonyl as biomarkers for oxidative stress and disease progression in patients with chronic myeloid leukemia.
Ahmad R; Tripathi AK; Tripathi P; Singh S; Singh R; Singh RK
In Vivo; 2008; 22(4):525-8. PubMed ID: 18712183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
